HOME >> MEDICINE >> NEWS
EVEREST data on use of tolvaptan published in JAMA and featured at ACC

PRINCETON, N.J., March 25, 2007-- Once-daily dosing with Otsuka's investigational oral medication tolvaptan, a vasopressin receptor antagonist, was associated with improvements in signs and symptoms of acutely decompensated heart failure (ADHF) in hospitalized patients receiving conventional care, without an adverse effect on their long-term survival versus placebo. These data are from the short- and long-term analyses of the international landmark trial Efficacy of Vasopressin antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) published in the March 28 issue of the Journal of the American Medical Association (JAMA). These data were presented at the American College of Cardiology's 56th Annual Scientific Sessions (ACC).

The phase 3 EVEREST trial, involving a total of 4,133 ADHF patients, represents three studies: a long-term outcomes trial evaluating patients after their discharge for a minimum of 60 days of treatment, and two identical, embedded short-term pivotal studies that examined tolvaptan compared to placebo over seven days of inpatient care or discharge, whichever came first.

Data from the two short-term studies documented that tolvaptan treatment yielded significantly greater improvements than placebo based on the primary endpoint (study A: p less than 0.001 and study B: p less than 0.001), which was the composite score of changes in patient-assessed global clinical status and changes in body weight at day seven or discharge. Long-term tolvaptan use did not differ from placebo on either of the study's two primary endpoints: deaths from all causes (p equal to 0.68) or from the combined endpoint of cardiovascular (CV) deaths or subsequent hospitalization for worsening HF (p equal to 0.55).

"Tolvaptan exhibited short-term symptomatic benefits in patients hospitalized with worsening heart failure," said investigator Marvin A. Konstam, M.D., chief of the Division of Cardiology at the Tufts- New England
'"/>

Contact: Debra Kaufmann
debra.kaufmann@otsuka.com
240-683-3568
Porter Novelli
27-Mar-2007


Page: 1 2 3 4 5

Related medicine news :

1. Is most published research really false?
2. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
3. In stroke, negative studies less likely to get published
4. Landmark study on diabetic foot infection published
5. New international standards for tuberculosis care published
6. Research published in the NEJM challenges 30-year-old standard of care for lupus patients
7. Newly published summer camp health guideline advises parents, camp directors
8. Child sex abuse policy recommendations published in Science magazine
9. Aqueous Humor Outflow featured in Investigative Ophthalmology & Visual Science
10. Health effects of functional foods featured during four-day symposium, Sept. 10-13
11. Rare, historic medical cartoons to be featured in film series

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EVEREST data use tolvaptan published JAMA and featured ACC

(Date:4/27/2015)... (PRWEB) April 27, 2015 On May 5, ... will ask their social media friends around the world to ... as asthma. , May 5 is World Pulmonary Hypertension ... a leader in the global PH community, will take part ... high blood pressure of the lungs. PH is an increase ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Ticket Down is ... in Philadelphia for his upcoming concert on Sunday, June ... will thrill his countless North American fans again in 2015 ... with his "Out There" tour. He will be performing ... able to listen to this legendary performer for the first ...
(Date:4/27/2015)... Doctors on Liens has been the ... for over twenty years. So when attorneys of personal injury ... in the Fresno area , Doctors on Liens responded with ... of medical specialists. With a medical group of chiropractors, ... Chiropractic is now helping more personal injury victims than ...
(Date:4/27/2015)... Douglas Fitzpatrick not only sells auto, life and ... helps secure homes for animals. On May 9, 2015 from ... booth at the 2015 Fetch A Friend Adopt-a-thon at the ... Ohio. , “I am very excited to be part ... pets from more than forty different rescues, shelters and animal ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram ... campaign to raise awareness of the vision of Mount ... Somesvara Temple. Ironically, when many of these people moved ... thought they were leaving the social and technological world ... of meditation, service to a higher cause, deep introspection, ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 3Health News:Paul McCartney Presale Tickets at Wells Fargo Center in Philadelphia: Ticket Down Slashes Paul McCartney Ticket Prices in Philadelphia at the Wells Fargo Center 2Health News:Eminent Doctor Joins Forces with Doctors on Liens in Fresno 2Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Mount Soma Monks Do Social Media 2
(Date:4/27/2015)... , April 27, 2015  Boston Scientific Corporation (NYSE: ... America Merrill Lynch 2015 Healthcare Conference on May 12 in ... Brennan , executive vice president and chief financial officer, and ... in a 30-minute question and answer session regarding the company ... A live webcast of the presentation and question and ...
(Date:4/27/2015)... and WASHINGTON , April 27, 2015 ... and SmartBrief recently partnered to deliver a daily newsletter ... the top news in the industry. The purpose of ... biotechnology manufacturers, GPOs, distributors and other specialty pharmacy stakeholders ... on April 27, 2015. "We are looking ...
(Date:4/27/2015)... , April 27, 2015 The ... estimated to grow to around $4,211.2 million by 2019, at ... Browse through the TOC of the North America ... of the in-depth analysis provided. It also provides a glimpse ... and is supported by various tables and figures. ...
Breaking Medicine Technology:Boston Scientific To Participate In The Bank Of America Merrill Lynch 2015 Healthcare Conference 2NASP and SmartBrief Partner on Specialty Pharmacy SmartBrief 2North America Ophthalmology Surgery Device Market is Expected to Reach $4,211.2 Million by 2019, at a CAGR of 5.0% From 2014 to 2019 2North America Ophthalmology Surgery Device Market is Expected to Reach $4,211.2 Million by 2019, at a CAGR of 5.0% From 2014 to 2019 3
Cached News: